The global blood coagulation analyzer market is projected to grow at a substantial CAGR of 5.9% over the period 2018 to 2023, driven by its increasing scope, product types, and applications.
The demand for coagulation testing, increasing healthcare expenditure, rapid development of hospitals and primary healthcare centers, growing occurrences of lifestyle-related conditions such as diabetes, obesity, and cardiovascular disorders, and developing healthcare infrastructure are other factors aiding the market growth. However, the high cost of devices and presence of alternatives is likely to hamper the growth of the blood coagulation analyzer market.
These are the latest findings of Radiant Insights, Inc. (San Francisco, CA, USA), a market intelligence and consulting firm.
Geographically, North America accounted for the largest share of the global blood coagulation analyzer market in 2015 and will continue to lead the market during the forecast period. The North American market is being driven by increased awareness of blood-related diseases among its people, rising prevalence of CVD and growing usage of coagulation analyzers in the region. The key players contributing to the robust growth of the blood coagulation analyzers market are entering into partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.
Go back
